iTeos Therapeutics, Inc. - Common stock, par value $0.001 per share (ITOS)

CUSIP: 46565G104

Q2 2023 13F Holders as of 30 Jun 2023

Holder snapshot 7 facts
Share change
-1,513,406
Put/Call ratio
79%
SEC-reported price per share
$13.24
Number of holders
140
Value change
-$20,449,873
Number of buys
70
Show 1 more fact
Number of sells
72
Security identity 1 fact
Shares outstanding
10,000

Security key

46565G104

Report period

Q2 2023

Institutions

140

Top holders

10

Ownership snapshot

Top reported holders of ITOS - iTeos Therapeutics, Inc. - Common stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Largest current holder
13D/G signal
Evidence rows
0
Latest as of
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

13F holder rows

Institutional holders as of Q2 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
140
Shares
34,539,222
Rows available
140
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders
149
Q2 2023 holders
140
Holder diff
-9
Investor Q1 2023 Shares Q2 2023 Shares Share Diff Share Chg % Q1 2023 value Q2 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .